Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

BG · Q3 2025 Earnings

Bunge Global

Reported November 5, 2025

30-second summary

30-second take: Bunge cut the full-year adjusted EPS guide to $7.30–$7.60 from the $7.75 point estimate held last quarter — a ~$0.30 midpoint reduction — and told investors to expect a "softer Q4" in both soy and softseed processing. Net interest expense guidance nearly doubled to $380–$400M from $220–$250M, and D&A jumped to ~$710M from ~$490M, reflecting the full weight of the Viterra balance sheet now landing on the P&L. The Q4 hockey stick from last quarter's 30/70 second-half framing has been replaced by an explicit H2 EPS range of $4.00–$4.25 — and management deferred any mid-cycle outlook to a March Investor Day.

Headline numbers

EPS

Q3 FY2025

$2.27

Revenue

Q3 FY2025

$22.16B

+71.7% YoY

Gross margin

Q3 FY2025

4.8%

Operating margin

Q3 FY2025

1.8%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$22.16B	+71.7%	$12.77B	+73.5%
EPS	$2.27	—	$1.31	+73.3%
Gross margin	4.8%	—	5.8%	-99bps
Operating margin	1.8%	—	4.2%	-240bps

Guidance

Full-year adjusted EPS lowered materially to $7.30–$7.60 from $7.75 point estimate; net interest expense guidance nearly doubled to $380–$400M, reflecting acquisition debt burden; D&A increased $220M YoY.

Guidance is issued for both next quarter and the full year. Both may appear below.

New guidance

Metric	Period	Guide	YoY
Second Half Adjusted EPS	FY 2025	$4.00 to $4.25	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EPS (Full Year)	FY 2025	$7.75	$7.30 to $7.60	-$0.15 to -$0.45 (midpoint lowered $0.30)	Lowered
Adjusted Annual Effective Tax Rate	FY 2025	21% to 25%	23% to 25%	Low end narrowed from 21% to 23% (+2 percentage points)	Raised
Net Interest Expense	FY 2025	$220 to $250 million (lower end)	$380 to $400 million	+$130 to +$180 million (guidance escalated dramatically)	Raised
Depreciation and Amortization	FY 2025	approximately $490 million	approximately $710 million	+$220 million	Raised

Reaffirmed unchanged this quarter: Capital Expenditures ($1.6 to $1.7 billion)

Segment performance

Q3 FY2025

Segment	Q3 FY2025	YoY
Soybean Processing and Refining	$10.857B	+38.2%
Softseed Processing and Refining	$3.661B	+130.3%
Other Oilseeds Processing and Refining	$1.207B	+13.4%
Grain Merchandising and Milling	$6.428B	+168.2%

Platform metrics

Q3 FY2025

Segment	Q3 FY2025
Soybeans Processed	12,139 thousand metric tons
Soybeans Merchandised	7,246 thousand metric tons
Softseeds Processed	3,129 thousand metric tons
Softseeds Merchandised	1,032 thousand metric tons
Grain Volumes Handled	24,080 thousand metric tons

Profitability

Q3 FY2025

Segment	Q3 FY2025
Adjusted Segment EBIT	$924 million
Adjusted Total EBIT	$757 million

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Share Repurchases	$545 million

Management tone

Narrative arc: Viterra waiting game → Viterra closes, EPS held → Viterra dilutive, EPS cut, integration first

Three months ago management held the $7.75 EPS guide on the strength of Processing offsetting a deteriorating R&SO outlook, with Viterra freshly closed and synergies described as a future tailwind. This quarter the deal is explicitly "mildly dilutive" to 2025, R&SO has been dissolved into the new segment structure, and the EPS guide is gone. "If Viterra was...mildly dilutive to the year...early indications are very good as a strong contributor...But I think into 2026, as we continue to work together...we'll see more and more of the benefits." That is a notable downshift from Q2's framing of Viterra as immediately accretive once regulatory holds lifted — and it explains why no synergy dollar target has materialized despite Q2's promise to issue a combined-company forecast.

Last quarter management said crush margin locks were limiting Q3 upside but framed the cycle as recovering. This quarter the framing is structural: "Probably don't see back to the 2023 levels...we do see we're at that part of the cycle where it feels like we're at the bottom of the cycle." "At the bottom of the cycle" is a meaningfully different message than "Q3 weakness from locks." It implies capacity overhang and supply abundance prevent a return to peak margins even with favorable RVO policy — a bear case Bunge had previously not validated.

The RVO policy bet that anchored Q2's R&SO defense has been deferred. Last quarter management waited on an August/September decision; this quarter the language is "we would like to think that we would start to see that improvement...early 26" combined with explicit acknowledgment of "technical limitations...whether it's really an issue, maybe it's not an issue, we don't really know yet" on the half-RIN foreign feedstock provision. Policy clarity has slipped a full quarter and the implementation pathway is now in question.

Most telling: the mid-cycle earnings power conversation has been punted to March. When asked about the post-Viterra earnings algorithm, management responded "Our plan is to share that with you in March at our Investor Day...we're going to recast everything." The pre-Viterra $11+ mid-cycle EPS anchor is implicitly off the table, with no replacement number on offer for four months.

Recurring themes management leaned on this quarter:

VITERA integration execution as near-term validation of deal thesis despite Q3 dilutionCommercial synergy realization dependent on regulatory separation lift now beginningBiofuel and trade policy clarity deferred to early 2026 as gate for margin recoverySpot market behavior and policy uncertainty driving conservative Q4 soybean/soft seed guidanceArgentina and Australia harvest upside to grain merchandising but balanced against global supply abundanceMega-project completion in 2026 enabling structural CapEx decline and elevated cash return optionality

Risks management surfaced:

Biofuel policy (RVO) timing and technical implementation risk on half-RIN foreign feedstock provision remains unresolvedTrade policy uncertainty (China program, Canada-China canola tensions) creating spot customer behavior and margin pressureLa Niña weather risk to 2026 crop supplies despite current abundant global grain stocksSoybean oil demand remaining weak in US (only exception to global strength) constraining crush economicsVITERA accounting/systems conversion complexity from IFRS private to GAAP public standards

Answers to last quarter's watch list

Combined-company forecast and Viterra synergy quantification — Not delivered. Management explicitly deferred a recast of the earnings algorithm to the March Investor Day. Viterra is now called "mildly dilutive" to 2025, with synergies expected to ramp in 2026–2027 but no dollar target attached.

Resolved negatively

Q3 EBIT and the implied Q4 needed to hit $7.75 — The $7.75 guide is gone. Q3 adjusted EPS came in at $2.27 and the new H2 range of $4.00–$4.25 implies a Q4 of roughly $1.85 at the midpoint — below Q3, and management explicitly flagged a "softer Q4" in both soy and softseed processing. The Q4 hockey stick didn't survive.

Resolved negatively

US RVO decision and R&SO read-through — Policy clarity slipped to "early 2026" and technical implementation risk on the half-RIN foreign feedstock provision was newly disclosed. The R&SO segment line itself was eliminated in the resegmentation, so direct comparison is no longer possible — but the underlying refining margin pressure remains unresolved.

Continue monitoring

Merchandising adjusted EBIT trajectory — The standalone Merchandising line ($27M in Q2) is gone, folded into Grain Merchandising & Milling at $6.43B post-Viterra. The spot-market dynamic management flagged in Q2 was reinforced this quarter: "farmers and end consumers remain largely spot, reflecting continued macro trade and biofuel policy uncertainty.".

Not resolved

Crush margin lock disclosure — No quantitative hedge ratio disclosed. Management's "bottom of the cycle" framing suggests forward locks are not capturing the policy-driven margin upside that would be needed to validate the original $7.75 guide.

Resolved negatively

What to watch into next quarter

Q4 adjusted EPS print against the implied ~$1.85 midpoint from the H2 $4.00–$4.25 range — a miss here puts the full-year low end of $7.30 at risk and would mark the second consecutive guide cut

March Investor Day mid-cycle EPS recast — specifically whether the new combined-company mid-cycle EPS anchor lands above, at, or below the pre-Viterra $11 reference point, and whether Viterra synergies finally get a dollar target and timeline

Net interest expense run-rate in Q4 — the $380–$400M FY guide implies a sharp step-up in H2; watch whether 2026 net interest stays elevated or whether management signals refinancing relief

Whether RVO half-RIN technical implementation gets resolved by the March Investor Day — if not, the "early 2026" margin recovery thesis slips to mid-2026 and the soy crush "bottom of the cycle" call gets tested

Capital returns cadence after Q3's $545M repurchase — with CapEx guided to $1.6–$1.7B and interest expense climbing, watch whether buyback pace moderates or management signals a 2026 cash deployment shift

Sources

Bunge Global Q3 2025 earnings press release (SEC EDGAR, filed November 5, 2025): https://www.sec.gov/Archives/edgar/data/1996862/000162828025049208/epr093020251.htm
Tapebrief Q2 2025 brief for BG (internal reference for prior guidance baseline)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.